Clinical trial
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
NCT00010257 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00010257 |
|---|---|
| Title | Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma |
| Official title | Phase II Study Of Carboplatin Plus Paclitaxel Treatment Of Advanced Thymoma Or Thymic Carcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thymoma, Thymic Carcinoma |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Enrollment | 46 |
| Start date | Jun 19, 2001 |
| Primary completion | Nov 1, 2008 |
| Completion | Aug 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 29, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: